Skip to main content
Premium Trial:

Request an Annual Quote

Oh, Oops

Cell lines aren't always what they are supposed to be, notes NPR's Richard Harris. A DNA test of a cancer cell line done a few years ago revealed that the supposed breast cancer cell line was, in actuality, a melanoma cell line.

But more than a thousand papers, Harris notes, had been published on the cell line, and despite articles being published revealing its contamination, some researchers continue to use it.

Contamination, he adds, is fairly common, with some studies suggesting that between 18 percent and 36 percent of cell lines are contaminated. But these days, Harries reports, there are more tools to catch it, like DNA testing of the cells.

"We do it routinely because we've made the mistake ourselves in the past," Georgetown University's Robert Clarke says.

Contamination, adds Stephen Ethier from the Medical University of South Carolina, is "actually not a difficult problem to fix."

"The hard part really is overcoming a mind-set in the field on how people work with cell lines," he adds.

 

 

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more